Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. reports developments as a life science tools company supplying mission-critical products and services to life sciences and advanced technology customers through its VWR Distribution & Services and Bioscience & Medtech Products businesses. Recurring updates cover earnings, cash flow, leverage, guidance, segment performance and the company’s Revival transformation program, including VWR brand activity, manufacturing and supply-chain improvements and e-commerce upgrades.
Company news also covers portfolio and infrastructure actions such as Masterflex fluid handling systems, single-use assemblies, peristaltic pumps, J.T. Baker high-purity process chemicals, and expanded microbial and stability testing capabilities for regulated biopharma manufacturing. Governance and management updates include finance leadership changes and appointments tied to bioscience, medtech products and enterprise transformation.
Avantor (NYSE: AVTR) announced its acquisition of Ritter GmbH for approximately €890 million in an all-cash deal, subject to adjustments and performance milestones. Ritter is a leading manufacturer of robotic and liquid handling consumables with a market potential of nearly $7 billion. This acquisition aims to enhance Avantor's offerings in the biopharma and healthcare sectors, and is expected to be accretive to adjusted EPS immediately upon closing. The deal will be financed through available cash and term loans, with a closing anticipated in Q3 2021.
Avantor, Inc. (NYSE: AVTR) will announce its Q1 2021 financial results on April 28, 2021, after market closure. A conference call is scheduled for 5:00 p.m. ET the same day, allowing investors to discuss the results. Interested participants can join via phone or access a live webcast through the company's website. Avantor, a Fortune 500 company, provides essential products and services across the biopharma, healthcare, and advanced technologies sectors, supported by a global presence that serves over 225,000 customer locations worldwide.
Avantor (NYSE: AVTR) announced a credit rating upgrade from Moody's Investor Services to 'Ba3' with a stable outlook, following similar upgrades from Fitch Ratings and S&P Global Ratings. This rating reflects Avantor's strong performance and resilience during challenging market conditions. The company's business model remains essential to its customers across various sectors, including biopharma and advanced technologies. This upgrade is expected to enhance investor confidence and potentially lower borrowing costs, further supporting Avantor's growth initiatives.
Avantor (NYSE: AVTR) will engage in a virtual fireside chat at the Raymond James 42nd Annual Institutional Investor Conference on March 1, 2021, starting at 4:40 p.m. Eastern Time. Michael Stubblefield, President and CEO, will represent the company. Investors can access the live webcast via Avantor's investor relations page, with a replay available until March 31, 2021. Avantor is a leading provider of mission-critical products and services across biopharma, healthcare, and advanced technologies, serving over 225,000 customer locations in 180 countries.
Avantor, Inc. (NYSE: AVTR) announced a significant upgrade in its credit rating to 'BB+' with a stable outlook by S&P Global Ratings on February 10, 2021. The company's CFO, Thomas Szlosek, expressed satisfaction with this acknowledgment, highlighting their strong operational performance amidst a challenging market environment. Avantor's integrated business model has been crucial in supporting customers across various research phases. The company serves over 225,000 customer locations globally, underscoring its extensive reach and infrastructure in the life sciences and advanced technologies sectors.
Avantor, Inc. (NYSE: AVTR) reported strong financial results for Q4 and the full year 2020, showcasing resilience in a challenging environment. Q4 net sales reached $1.791 billion, up 17.5% YoY, with organic growth of 14.9%. The company generated $286 million in free cash flow. For the full year, net sales were $6.394 billion, marking a 5.8% increase, and free cash flow surged 187% to $868.2 million. Adjusted EPS rose to $0.29 in Q4, while full-year adjusted EPS increased to $0.89. The company is well-positioned as a critical partner in fighting diseases, including COVID-19.
Avantor, Inc. (NYSE: AVTR) has declared a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, representing a yield of 1.560%. This dividend will be payable on February 15, 2021 to shareholders on record as of February 1, 2021. The company emphasizes its commitment to enhancing shareholder value while maintaining a strong global presence in the life sciences and advanced materials sectors.
Avantor, a global provider of mission-critical products and services, will announce its fourth quarter and full year 2020 financial results after the market closes on February 3, 2021. A conference call to discuss these results will be held at 5:00 p.m. ET on the same day. Participants can join via phone or through a live webcast on the company's website. Avantor serves more than 225,000 customer locations globally, operating in key industries such as biopharma and healthcare.
Avantor (NYSE: AVTR) announced preliminary unaudited revenues for Q4 2020, estimating approximately $1.79B, reflecting an organic revenue growth of ~15%. The free cash flow is estimated at over $270M, significantly higher than $74.9M in Q4 2019. The results, to be finalized soon, align with the company's ongoing performance in life sciences and advanced materials. Management will present 2021 revenue expectations at the J.P. Morgan Healthcare Conference. Notably, these preliminary results are unaudited and may change upon final review.
Avantor (NYSE: AVTR) has announced a global initiative to support communities amid the COVID-19 pandemic. The company is donating over 1.5 million surgical masks and thermometers to schools in Mumbai and Delhi. Additionally, Avantor Foundation has granted nearly $350,000 to various organizations focusing on healthcare and STEM education. These efforts align with Avantor's mission to promote science for goodness and enhance patient outcomes through educational support and healthcare improvements.